BIO-Europe 2024
Tsingke will participate in BIO-Europe 2024, the premier global biotechnology event, taking place from November 4 to 6 in Stockholm, Sweden. BIO-Europe gathers leading companies and institutions from ...
Tsingke Successfully Showcases Innovations at BIO-Europe 2024
Tsingke proudly concluded its participation in BIO-Europe 2024, held from November 4 to 6 in Stockholm, Sweden. As one of the premier global events for the biotechnology, pharmaceutical, and investmen...
Tsingke Biotech Showcased AI-Powered Biomanufacturing Solutions at 2025 Festival of Biologics
Publication Date: Oct 28, 2025
Protein & Antibody
From recombinant protein expression to monoclonal and polyclonal antibody generation, Tsingke delivers end-to-end services backed by validated expression systems and purification protocols. Flexible expression hosts and scalable production enable customized solutions for diagnostics, therapeutics, and assay development.
Antibody Drug Discovery
We offer GMP-ready gene synthesis, vector construction, and nucleic acid production for therapeutic applications. With capabilities in mRNA,saRNA, circRNA, and viralvector backbones, Tsingke supports ...
Oncology & Genetic Testing
Advancements in oncology and genetic testing rely on the precise detection of somatic and germline variants. Tsingke offers tailored NGS panels, qPCR assays, and specialized probes to support liquid biopsy, hereditary cancer risk assessment, and companion diagnostic development.
mRNA Vaccines
mRNA vaccine technology represents a transformative approach with rapid development and high efficacy. Tsingke provides end-to-end solutions, from codon-optimized antigen design and IVT mRNA synthesis to saRNA and LNP encapsulation, enabling you to respond swiftly to emerging infectious threats.
CRISPR gRNA Synthesis
CRISPR gene editing relies on high-quality guide RNAs (gRNAs) to ensure precise and efficient cutting.
Tsingke provides synthetic sgRNAs, crRNAs, and tracrRNAs that are chemically modified for enhanced stability and reduced off-target effects, empowering researchers to achieve reliable and reproducible editing outcomes across various cell types and organisms.
mRNA & saRNA
Messenger RNA (mRNA) and self-amplifying RNA (saRNA) technologies have revolutionized the development of vaccines and protein replacement therapies.
Tsingke offers robust and scalable synthesis of these RNA molecules, incorporating critical modifications to enhance translation and reduce immunogenicity.
Animal Health
Protecting animal health is crucial for food security, animal welfare, and preventing zoonotic diseases. Tsingke supports the animal health industry by providing the precise DNA, RNA, and oligonucleotide components needed for vaccines, molecular diagnostics, and therapeutic agents targeting key veterinary pathogens.
Cell & Gene Therapy International 2024
Get Ready for the Future of Cell & Gene Therapies 2024!Join us from September 23-26, 2024, at the Hynes Convention Center in Boston, MA, for Cell & Gene Therapies. This event will feature over...
Stay updated with the latest industry news and expert insights.
Subscribe now to receive:
● Industry updates
● Exclusive expert insights and analysis
Enter your email to stay ahead!
